Ledger.Open graph →
SEC Form D · filed June 4, 2025

CollPlant Biotechnologies Ltd

Offering
$3.9M
Sold
$3.9M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
REHOVOT, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Roger D. Pomerantz · Rehovot, L3DirectorAbraham D. Havron · Rehovot, L3DirectorAlisa D. Lask · Rehovot, L3DirectorJoseph D. Zarzewsky · Rehovot, L3DirectorHugh D. Evans · Rehovot, L3DirectorYehiel Tal · Ness-Ziona, L3Exec · DirectorHadas D. Horowitz · Rehovot, L3ExecElana Gazal · Rehovot, L3ExecPhilippe Bensimon · Ness-Ziona, L3ExecEran Rotem · Ness-Ziona, L3ExecOren Fahimipoor · Rehovot, L3ExecElan D. Penn · Rehovot, L3DirectorRoger D. Pomerantz · Rehovot, L3DirectorHugh D. Evans · Rehovot, L3DirectorYehiel Tal · Ness-Ziona, L3Exec · DirectorHadas D. Horowitz · Rehovot, L3ExecAbraham D. Havron · Rehovot, L3DirectorElana Gazal · Rehovot, L3ExecAlisa D. Lask · Rehovot, L3DirectorPhilippe Bensimon · Ness-Ziona, L3ExecEran Rotem · Ness-Ziona, L3ExecJoseph D. Zarzewsky · Rehovot, L3DirectorOren Fahimipoor · Rehovot, L3ExecElan D. Penn · Rehovot, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗